{"id":"https://openalex.org/W7219568466","doi":"https://doi.org/10.34172/jcvtr.33675","title":"Impact of Empagliflozin on mRNA Levels of Cardiotrophin-1 and GDF-15 in Patients with Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Double-Blind Pilot Trial","display_name":"Impact of Empagliflozin on mRNA Levels of Cardiotrophin-1 and GDF-15 in Patients with Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Double-Blind Pilot Trial","publication_year":2026,"publication_date":"2026-06-30","ids":{"openalex":"https://openalex.org/W7219568466","doi":"https://doi.org/10.34172/jcvtr.33675","pmid":"https://pubmed.ncbi.nlm.nih.gov/42898280","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13677614"},"language":"en","primary_location":{"id":"doi:10.34172/jcvtr.33675","doi":"https://doi.org/10.34172/jcvtr.33675","is_oa":true,"landing_page_url":"https://doi.org/10.34172/jcvtr.33675","pdf_url":"https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-18-116.pdf","source":{"id":"https://openalex.org/S2764404160","display_name":"Journal of Cardiovascular and Thoracic Research","issn_l":"2008-5117","issn":["2008-5117","2008-6830"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319102","host_organization_name":"Tabriz University of Medical Sciences","host_organization_lineage":["https://openalex.org/P4310319102"],"host_organization_lineage_names":["Tabriz University of Medical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular and Thoracic Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-18-116.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055342527","display_name":"Reza Rastgoo Sisakht","orcid":"https://orcid.org/0009-0001-9289-2717","observed_orcids":["https://orcid.org/0009-0001-9289-2717"]},"institutions":[{"id":"https://openalex.org/I116768543","display_name":"Zanjan University of Medical Sciences","ror":"https://ror.org/01xf7jb19","country_code":"IR","type":"education","lineage":["https://openalex.org/I116768543"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Reza Rastgoo","raw_affiliation_strings":["Department Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran"],"raw_orcid":"https://orcid.org/0009-0001-9289-2717","affiliations":[{"raw_affiliation_string":"Department Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran","institution_ids":["https://openalex.org/I116768543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157015622","display_name":"Mahnaz Yousefi Ramandi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I116768543","display_name":"Zanjan University of Medical Sciences","ror":"https://ror.org/01xf7jb19","country_code":"IR","type":"education","lineage":["https://openalex.org/I116768543"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mahnaz Yousefi Ramandi","raw_affiliation_strings":["Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran","institution_ids":["https://openalex.org/I116768543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036262055","display_name":"Fereshteh Ebrahimi","orcid":"https://orcid.org/0000-0001-8923-0109","observed_orcids":["https://orcid.org/0000-0001-8923-0109"]},"institutions":[{"id":"https://openalex.org/I116768543","display_name":"Zanjan University of Medical Sciences","ror":"https://ror.org/01xf7jb19","country_code":"IR","type":"education","lineage":["https://openalex.org/I116768543"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Fereshteh Ebrahimi","raw_affiliation_strings":["Department Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran","institution_ids":["https://openalex.org/I116768543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021167377","display_name":"Reza Madadi","orcid":"https://orcid.org/0000-0003-1543-420X","observed_orcids":["https://orcid.org/0000-0003-1543-420X"]},"institutions":[{"id":"https://openalex.org/I116768543","display_name":"Zanjan University of Medical Sciences","ror":"https://ror.org/01xf7jb19","country_code":"IR","type":"education","lineage":["https://openalex.org/I116768543"]}],"countries":["IR"],"is_corresponding":true,"raw_author_name":"Reza Madadi","raw_affiliation_strings":["Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran"],"raw_orcid":"https://orcid.org/0000-0003-1543-420X","affiliations":[{"raw_affiliation_string":"Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran","institution_ids":["https://openalex.org/I116768543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037368949","display_name":"Hamid Khederlou","orcid":"https://orcid.org/0000-0001-8606-2381","observed_orcids":["https://orcid.org/0000-0001-8606-2381"]},"institutions":[{"id":"https://openalex.org/I116768543","display_name":"Zanjan University of Medical Sciences","ror":"https://ror.org/01xf7jb19","country_code":"IR","type":"education","lineage":["https://openalex.org/I116768543"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Hamid Khederlou","raw_affiliation_strings":["Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran","institution_ids":["https://openalex.org/I116768543"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045805474","display_name":"Ali Ramazani","orcid":"https://orcid.org/0000-0003-0369-2981","observed_orcids":["https://orcid.org/0000-0003-0369-2981","https://orcid.org/0000-0003-3072-7924"]},"institutions":[{"id":"https://openalex.org/I116768543","display_name":"Zanjan University of Medical Sciences","ror":"https://ror.org/01xf7jb19","country_code":"IR","type":"education","lineage":["https://openalex.org/I116768543"]}],"countries":["IR"],"is_corresponding":true,"raw_author_name":"Ali Ramazani","raw_affiliation_strings":["Department Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran"],"raw_orcid":"https://orcid.org/0000-0003-0369-2981","affiliations":[{"raw_affiliation_string":"Department Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran","institution_ids":["https://openalex.org/I116768543"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021167377","https://openalex.org/A5045805474"],"corresponding_institution_ids":["https://openalex.org/I116768543"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.74105724,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"2","first_page":"116","last_page":"122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13452","display_name":"GDF15 and Related Biomarkers","score":0.5292999744415283,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13452","display_name":"GDF15 and Related Biomarkers","score":0.5292999744415283,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.2915000021457672,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.05249999836087227,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cardiotrophin-1","display_name":"cardiotrophin-1","score":0.9300000071525574},{"id":"https://openalex.org/keywords/growth-differentiation-factor-15","display_name":"growth differentiation factor 15","score":0.9599999785423279},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9419999718666077},{"id":"https://openalex.org/keywords/st-elevation-myocardial-infarction","display_name":"ST-elevation myocardial infarction","score":0.9950000047683716},{"id":"https://openalex.org/keywords/primary-percutaneous-coronary-intervention","display_name":"primary percutaneous coronary intervention","score":0.9580000042915344},{"id":"https://openalex.org/keywords/circulating-monocytes","display_name":"circulating monocytes","score":0.9350000023841858},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.7699999809265137},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.8980000019073486},{"id":"https://openalex.org/keywords/anti-atherosclerotic-effects","display_name":"anti-atherosclerotic effects","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.7400000095367432},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.996999979019165},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9944999814033508},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9108999967575073},{"id":"https://openalex.org/C2780652884","wikidata":"https://www.wikidata.org/wiki/Q5323607","display_name":"EMPA","level":3,"score":0.7867000102996826},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7533000111579895},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7148000001907349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6757000088691711},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5878999829292297},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5539000034332275},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4424999952316284},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.41769999265670776},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.39480000734329224},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3698999881744385},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.32499998807907104},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31290000677108765},{"id":"https://openalex.org/C3017583242","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Placebo group","level":4,"score":0.3028999865055084},{"id":"https://openalex.org/C2780665704","wikidata":"https://www.wikidata.org/wiki/Q959298","display_name":"Intervention (counseling)","level":2,"score":0.27410000562667847},{"id":"https://openalex.org/C2778742482","wikidata":"https://www.wikidata.org/wiki/Q816759","display_name":"Beta blocker","level":3,"score":0.2524000108242035}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.34172/jcvtr.33675","doi":"https://doi.org/10.34172/jcvtr.33675","is_oa":true,"landing_page_url":"https://doi.org/10.34172/jcvtr.33675","pdf_url":"https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-18-116.pdf","source":{"id":"https://openalex.org/S2764404160","display_name":"Journal of Cardiovascular and Thoracic Research","issn_l":"2008-5117","issn":["2008-5117","2008-6830"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319102","host_organization_name":"Tabriz University of Medical Sciences","host_organization_lineage":["https://openalex.org/P4310319102"],"host_organization_lineage_names":["Tabriz University of Medical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular and Thoracic Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13677614","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677614/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677614/pdf/jcvtr-18-116.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Cardiovasc Thorac Res","raw_type":"Text"},{"id":"pmid:42898280","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42898280","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular and thoracic research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.34172/jcvtr.33675","doi":"https://doi.org/10.34172/jcvtr.33675","is_oa":true,"landing_page_url":"https://doi.org/10.34172/jcvtr.33675","pdf_url":"https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-18-116.pdf","source":{"id":"https://openalex.org/S2764404160","display_name":"Journal of Cardiovascular and Thoracic Research","issn_l":"2008-5117","issn":["2008-5117","2008-6830"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319102","host_organization_name":"Tabriz University of Medical Sciences","host_organization_lineage":["https://openalex.org/P4310319102"],"host_organization_lineage_names":["Tabriz University of Medical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular and Thoracic Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7219568466.pdf","grobid_xml":"https://content.openalex.org/works/W7219568466.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1816376135","https://openalex.org/W1979790690","https://openalex.org/W2058302382","https://openalex.org/W2099172760","https://openalex.org/W2102785524","https://openalex.org/W2132354411","https://openalex.org/W2146264128","https://openalex.org/W2158945113","https://openalex.org/W2161682643","https://openalex.org/W2166575974","https://openalex.org/W2406421093","https://openalex.org/W2520258205","https://openalex.org/W2774743973","https://openalex.org/W2789662105","https://openalex.org/W2810428191","https://openalex.org/W2911166645","https://openalex.org/W2912560149","https://openalex.org/W2923631090","https://openalex.org/W2969924040","https://openalex.org/W3005920016","https://openalex.org/W3026518964","https://openalex.org/W3212764215","https://openalex.org/W4214694796","https://openalex.org/W4224121636","https://openalex.org/W4283660705","https://openalex.org/W4367367436","https://openalex.org/W4387328336","https://openalex.org/W4387366326","https://openalex.org/W4388694196","https://openalex.org/W4402428803","https://openalex.org/W4405402258","https://openalex.org/W4409338088","https://openalex.org/W4409449397","https://openalex.org/W4410756505"],"related_works":["https://openalex.org/W7202032147","https://openalex.org/W4400536929","https://openalex.org/W3188095342","https://openalex.org/W4386958270","https://openalex.org/W4315778361","https://openalex.org/W4405418588","https://openalex.org/W3120992799","https://openalex.org/W3216226715","https://openalex.org/W4405809532","https://openalex.org/W4309400086"],"abstract_inverted_index":{"Introduction:":[0],"Given":[1],"the":[2,13,140,148,162,216],"proven":[3],"cardiovascular":[4],"benefits":[5],"of":[6,15,54,58,85,177,218,240,245],"Empagliflozin":[7,16],"(EM),":[8],"we":[9],"aimed":[10],"to":[11,46,56,80,134],"investigate":[12],"effect":[14,239],"on":[17],"Cardiotrophin-1":[18],"(CTF-1)":[19],"and":[20,67,103,153,167,181,189,207,220,234,247],"growth":[21],"differentiation":[22],"factor-15":[23],"(GDF-15)":[24],"expressions":[25],"in":[26,29,50,116,129,147,154,161,168,204,222],"circulating":[27],"monocytes":[28],"type":[30,64,223],"2":[31,65,224],"diabetic":[32],"patients":[33,44,62,113],"after":[34,210],"MI.":[35],"Methods:":[36],"This":[37],"randomized,":[38],"double-blind,":[39],"placebo-controlled":[40],"study":[41,118],"included":[42,115],"33":[43],"referred":[45],"Ayatollah":[47],"Mousavi":[48],"Hospital":[49],"Zanjan":[51],"between":[52],"5":[53],"September":[55],"25":[57],"December,":[59],"2024.":[60],"Eligible":[61],"with":[63,196,232],"diabetes":[66,125],"MI":[68,227],"who":[69],"underwent":[70],"primary":[71],"percutaneous":[72],"coronary":[73],"intervention":[74,130,149,163],"(PCI)":[75],"were":[76,97,105,114,193],"randomly":[77],"assigned":[78],"(17:16)":[79],"receive":[81],"either":[82],"10":[83],"mg":[84],"EMPA":[86,173,213,241],"daily":[87],"or":[88],"placebo":[89,135,155,169],"for":[90],"12":[91],"weeks.":[92],"Target":[93],"genes":[94],"expression":[95,146,160,176,191,217],"levels":[96],"quantified":[98],"by":[99,107],"real":[100],"time":[101],"PCR,":[102],"data":[104],"analyzed":[106],"SPSS":[108],"version":[109],"26.":[110],"Results:":[111],"Thirty-three":[112],"this":[117],"(mean":[119],"age:":[120],"61.27\u00b19.07,":[121],"66%":[122],"male),":[123],"mean":[124],"duration":[126],"was":[127,139,151,157,165,171],"longer":[128],"group":[131,136,150,156,164,170],"(7.82\u00b15.13)":[132],"compared":[133],"(3.75\u00b12.74),":[137],"hypertension":[138],"most":[141],"common":[142],"comorbidity":[143],"(57%).":[144],"CTF-1":[145,178,188,219,248],"0.3\u00b10.28":[152],"5.66\u00b16.52.":[158],"GDF-15":[159,182,190,221,246],"0.198\u00b10.22":[166],"1.66\u00b11.04.":[172],"significantly":[174,214],"reduced":[175,215],"(13-fold)":[179],"(P=0.003)":[180],"(7-fold)":[183],"(P":[184],"\u02c2":[185],"0.0001).":[186],"The":[187],"reduction":[192,202],"not":[194],"associated":[195,231],"any":[197],"other":[198],"clinical":[199],"variables.":[200],"Significant":[201],"observed":[203],"LDL":[205],"(P=0.045)":[206],"triglycerides":[208],"(P=0.013)":[209],"intervention.":[211],"Conclusion:":[212],"diabetic,":[225],"post":[226],"patients,":[228],"which":[229],"are":[230],"atherosclerosis,":[233],"suggest":[235],"that":[236],"potential":[237],"anti-atherosclerotic":[238],"mediated":[242],"through":[243],"modulation":[244],"gene":[249],"expression.":[250]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-05T00:00:00"}